A soluble recombinant version of a new Treponema pallidum outer membrane protein, known as Tp0663, has been produced for the diagnosis of syphilis.
The recombinant protein exhibited a superior serodiagnostic performance to the ARCHITECT Syphilis TP chemiluminescent immunoassay (Abbott GmbH & Co. KG) when 3326 characterized serum samples were screened with the two tests.
The Tp0663-based ELISA was in perfect agreement with clinical diagnosis (gold standard) with a κ value of 0.99, comparable to that of ARCHITECT Syphilis TP (0.96).
Tp0663 may represent a novel candidate with highly accurate diagnosis for the seroscreening of syphilis.